Hyperkalaemia: isotonic bicarbonate infusions offered no real benefit in lowering potassium.
|
|
|
Clinical bottom line (level 3b)
-
Isotonic bicarbonate infusions over one hour did not have a clinically significant effect in potentiating the potassium-lowering effect of insulin in patients with end-stage renal disease on maintenance haemodialysis.
|
|
Allon and Shanklin:
American Journal of Kidney Disease
1996;
28 (4):
508-514
|
Expires
February 2004
|
The study
Case-control study
with
objective
outcomes,
not adjusted
for confounding factors,
not
validated in an independent set of patients.
Setting: outpatient dialysis unit, university hospital, USA
8 patients
(aged
mean 50 years,
88%
male)
nondiabetic chronic haemodialysis patients receiving 3-4 hours of dialysis three times a week, for at least three months
Excluded if
angina
myocardial infarction within 6 months
excessive (>3/min) or complex ventricular premature beats
using beta-blockers
Control Group: (n = 8, 8 analysed):
isotonic saline, given as experimental group
Experimental Group: (n = 8, 8 analysed):
Isotonic bicarbonate in 10% dextrose at 90 mmol/l and IV insulin (5 mU/kg/min) for 60 minutes; total volume administered 600 mL. Given with or without albuterol.
100% followed for
60
minutes
The evidence
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| change in potassium (mol/l) without albuterol
|
-0.85
(0.06)
|
-0.81
(0.15)
|
-0.04
(-0.16 to 0.08)
|
| change in potassium with albuterol
|
-0.53
(0.15)
|
-0.71
(0.16)
|
0.18
(0.01 to 0.34)
|
No change in pH or arterial bicarbonate was found on any regimen.
Comments
- Non-ideal study design (non-randomised, unblinded and very small).
- Patients were neither very hyperkalaemia (eg. potassium of around 4.2) nor acidaemic (pH at baseline 7.39).
- Isotonic bicarbonate infusions were used because of previous studies showing lack of effect of bolus hypertonic bicarbonate.
Citation
-
Allon
M,
and
Shanklin
N:
Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
American Journal of Kidney Disease
1996;
28 (4):
508-514
Contributor: Warren Lee, Chris Ball and Clare Wotton,
February 2000
Reviewer:
Clinical Question.
| Patient |
chronic haemodialysis |
| Intervention or Exposure |
isotonic bicarbonate |
| Comparison |
placebo |
| Outcome |
fall in potassium |
|
|